Vanguard Capital Management’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Vanguard Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58K	Buy	+12,085	New	+$166K	﹤0.01%	3905

Other funds holding MEDS

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VFIC

Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return

Vanguard Capital Management's MEDS Position: Q1 2026 in Review

Vanguard Capital Management opened a new position in DataMeds AI, Inc. Common Stock (MEDS) in Q1 2026: 12,085 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #3905 among its holdings.

13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

Vanguard Capital Management held 12,085 shares of DataMeds AI, Inc. Common Stock worth $58K as of Q1 2026.
DataMeds AI, Inc. Common Stock was a new Vanguard Capital Management position in Q1 2026.
DataMeds AI, Inc. Common Stock made up ﹤0.01% of Vanguard Capital Management's portfolio in Q1 2026, its #3905 holding.
13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.